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Abstract.  Many hemopoietic cell lines were examined 
for their ability to adhere to culture dishes coated with 
extracellular matrix proteins.  Adhesion assay was per- 
formed with murine and human leukemic cell lines 
representative of different stages of differentiation 
along both erythroid and myeloid lineages. All the 
hemopoietic cell lines tested adhered to fibronectin but 
not to laminin, types I, III, and IV collagen, serum- 
spreading factor, and cartilage proteoglycans. In addi- 
tion to immortalized cell lines, immature erythroid and 
myeloid mouse bone marrow cells adhered to fibronec- 
tin. To define the fibronectin region involved in hemo- 
poietic cell adhesion, proteolytic fragments, mono- 
clonal antibodies, and synthetic peptides were used. 
Among different fibronectin fragments tested, only a 
ll0-kD polypeptide, corresponding to the fibroblast 
attachment domain, was active in promoting adhesion. 
Moreover, a  monoclonal antibody to the cell binding 
site located within this domain prevented hemo- 
poietic cell adhesion. Finally, the tetrapeptide 
Arg-Gly-Asp-Ser, which corresponds to the fibronectin 
sequence recognized by fibroblastic cells, specifically 
and competitively inhibited attachment of hemopoietic 
cells to this molecule. The cell surface molecule in- 
volved in the interaction of mouse hemopoietic cells 
with fibronectin was identified as a  145,000-D  mem- 
brane glycoprotein by adhesion-blocking antibodies. 
This glycoprotein was found to be antigenically and 
functionally related to the GP135 membrane glycopro- 
tein involved in the adhesion of fibroblasts to fibronec- 
tin (Giancotti, F.  G., P.  M.  Comoglio, and G. Tarone, 
1986, Exp. Cell Res.,  163:47-62).  On the basis of 
these data, we conclude that interaction of hemopo!etic 
cells with fibronectin involves a  specific fibronectin 
sequence and a  145,000-D  cell surface glycoprotein. 
We speculate that this property might be relevant for 
the interaction of hemopoietic cells with the bone 
marrow stroma, which represents the natural site of 
hemopoiesis. 
F 
IBRONECTIN is a major glycoprotein component of the 
extracellular matrix and is known to promote cell 
adhesion and to affect growth and differentiation (17). 
The molecular aspects of its interaction with fibroblasts have 
been defined in detail. The site responsible for binding with 
the cell surface receptor has been identified and shown to 
contain the active sequence Arg-Gly-Asp-Ser (28).  More- 
over, plasma membrane glycoproteins of "~140,000 D were 
identified in different fibroblast species as putative fibronec- 
tin receptors (3, 9,  13, 25,  30). 
In this paper we have investigated the interaction of hemo- 
poietic cells with fibronectin. The bone marrow stroma is 
thought to be required for the specific lodgment, prolifera- 
tion, and differentiation of hemopoietic progenitor cells in 
vivo (41). The importance of bone marrow stroma is also 
demonstrated by in vitro cultures, in which the long term 
production of hemopoietic cells depends on the formation of 
a monolayer of bone marrow-derived stromal cells (5, 32). 
Tl,~e bone marrow stroma consists of fibroblasts, adipocytes, 
and endothelial cells (38),  as well as extracellular matrix 
proteins such as types I, III, and IV collagen, fibronectin, 
laminin, and proteoglycans (1,  16, 43). Since actively divid- 
ing hemopoietic progenitor ceils are preferentially associ- 
ated with the stromal layer of bone marrow cultures (4, 12), 
it is possible that certain components of this matrix play a 
role in the maintenance of hemopoiesis. This possibility is 
also suggested by the observation that inhibitors of matrix 
formation decrease stem cell production (44), whereas com- 
pounds that stimulate matrix production increase stem cell 
proliferation (34). Moreover, immunofluorescence studies of 
the developing bone have indicated that hemopoietic colo- 
nies are associated with fibronectin-rich areas of the bone 
marrow (40), suggesting a possible role of this protein in an- 
choring hemopoietic cells to the stroma. In accordance with 
this hypothesis, it was reported that murine erythroleukemia 
cells adhere to fibronectin in an in vitro assay (26). 
In this paper we demonstrate that immature myeloid and 
erythroid cells can adhere to fibronectin. Adhesion occurs 
via  the  same  cell  attachment domain  and  active  site  of 
fibronectin that functions in fibroblast adhesion. Moreover, 
antibodies  to  a  145-kD  plasma  membrane  glycoprotein, 
which  is  structurally and immunologically related to the 
GP135  molecule that  mediates  adhesion of fibroblasts  to 
fibronectin, can prevent hemopoietic cell adhesion (9,  10). 
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Materials 
Fibronectin was purified from human plasma by affinity chromatography 
on denatured collagen (gelatin), as already reported (36). Fibronectin frag- 
ments,  corresponding to  the  Hep-l/Fib-1  (28  kD),  Gel  (40  kD),  Cell 
(110 kD), and Fib-2 (20 kD) domains of  the molecule, were kindly provided 
by L. Zardi (Istituto Nazionale per la Ricerca sul Cancro, Genova). These 
were obtained by thermolysin digestion of the intact molecule and were 
separated by  chromatography  on hydroxylapatite column  (42).  Serum- 
spreading factor preparations consisted of fetal calf serum (Flow Laborato- 
ries, Inc., McLean, VA) adsorbed on Sepharose-coupled gelatin to remove 
flbronectin and on Affi-gel Blue (Bio-Rad Laboratories, Richmond, CA) to 
remove albumin  (14). These preparations  were  shown to  be devoid of 
fibronectin by radioimmunoassay (37) and effectively promoted attachment 
of murine fibroblasts in a dose-dependent manner also in the presence of 
flbronectin antibodies. Laminin was purchased from Bethesda Research 
Laboratories (Gaithersburg, MD), bovine dermal collagen (95 % type I  + 
5%  type ill)  was  from Flow Laboratories (Vitrogen  100), and  human 
placenta basement membrane collagen (type IV) and gelatin (swine skin 
denatured collagen) were from Sigma Chemical Co. (St. Louis, MO). Bo- 
vine nasal and chick sternal cartilage proteoglycans were a kind gift of M. 
Pacifici (University of Pennsylvania, Philadelphia). The cell attachment 
promoting fibronectin peptide Arg-Gly-Asp-Ser and the inactive one, Gly- 
Arg-Gly-Gin-Ser-Pro, were kind gifts of H.  Richter (Max Planck Insti- 
tute, Martinsreed) and E. Dejana (Istituto "M. Negri,  ~ Milano), respective- 
ly.  Substance P  (Arg-Pro-Lys-Pro-Gln-Phe-Phe-Gly-Leu-Met-NH2), also 
used as  control peptide,  was  purchased  from  UCB-Bioproducts S.  A. 
(Braine-L'Alleud, Belgium). 
Cells 
Murine hemopoietic cell lines included Friend erythroleukemia clone 745 
E  and WEHI-3B  D+  myelomonocytic leukemia ceils (24).  These were 
provided by G. B. Rossi (Istituto Superiore di Sanith, Roma) and W. Pia- 
cibello (Universit~t di Torinn, Italy), respectively. Human hemopoietic cells 
included the following leukemia cell lines: K-562 (undifferentiated), KG-1 
(myeloblastic), HL-60 (promyelocytic), and U93"/(monoblastic-monocyt- 
ic) (7). KG-I and K-562 were obtained from American Type Culture Collec- 
tion (Rockville, MD), HL-60 were provided by C. Tarella (Ospedale Mag- 
giore  "S.  Giovanni  Battista,"  Torino,  Italy),  and  U937  by  E  Malavasi 
(Universi~ di Torino, Italy). The KG-I line was grown in Iscove's modified 
Eagle's medium supplemented with 20%  fetal calf serum. All the other 
hemopoietic  cell  lines  were  propagated  in  RPMI  1640 medium  sup- 
plemented with 10% fetal calf serum. The Hep-G2 human hepatoma cell 
line, obtained from Dr. G. Actis (Ospedale Maggiore "S. Giovanni Battista," 
Torino, Italy), SR-BALB mouse fibroblasts (9), and baby hamster kidney 
(BHK) ~ ceils are routinely cultured in our laboratory in Dulbecco's mod- 
ified Eagle's medium supplemented with 10%  fetal calf serum. 
Murine bone marrow cells were prepared by flushing femur shafts with 
RPMI 1640 medium plus 5 % fetal calf serum. Debris were sedimented at 
1 g, and cells were washed three times with serum-free RPMI. 
Antibodies 
The anti-BHK serum was prepared by injecting rabbits with intact cells, as 
previously described (35).  Before use,  the antiserum was adsorbed on 
Sepharose-coupled hamster fibronectin to remove the corresponding anti- 
bodies (36). An IgG fraction of this antiserum was prepared by chromatog- 
raphy on Sepharose-coupled protein A (Pharmacia Fine Chemicals, Div. of 
Pharmacia Inc., Piscataway,  NJ). Monospecific antibodies to GP135 were 
purified from the anti-BHK IgGs using the antigen immobilized on nitrocel- 
lulose filter,  as previously described (10). Briefly,  [3SS]methionine-labeled 
cell surface proteins were immunoprecipitated from  1  x  l0  s SR-BALB 
mouse fibroblasts with the anti-BHK serum, separated by SDS PAGE under 
noureducing conditions, and electrophoretically transferred to nitrocellu- 
lose paper by Western blotting (see below). The nitrocellulose fragment cor- 
responding to GPI35 was localized  by autoradiography  and excised.  After 
saturation  with 5% bovine serum albumin (BSA), the nitrocellulose  frag- 
ment was incubated with 20 rng/rnl  of anti-BHK IgGs. After extensive 
washing  with pbosphate-buffered saline (PBS), bound antibodies were 
eluted  in I00 Itl  of  apH 3 buffer  (28.5  mM  citric  acid,  29 mM  potassium 
phosphate,  0.52%  barbital, and  19  mM  boric acid) containing 
I. Abbreviation used in this  paper: BHK, baby hamster kidney. 
10 I~g/ml of carrier BSA and immediately neutralized. Antibodies from 10 
purification cycles were pooled and concentrated. A  typical preparation 
consisted of '~50  I~g of purified antibodies. Each batch was tested  for 
specificity by immunoblotting on a crude membrane fraction of SR-BALB 
mouse fibroblasts, as previously described (10). 
The monoclonal antibody f 33, directed toward the cell binding site of 
fibronectin (33), was kindly provided by V. Miggiano (Hoffmann-LaRoche, 
Basel) and S. Barlati (Universit~ di Brescia, Italy). The monocioual anti- 
body MAB 52, reacting with the gelatin binding region of fibronectin, was 
isolated in our laboratory (37). 
Adhesion Assay 
Adhesion to coated dishes was measured using a previously described assay 
(9, 36). In experiments designed to compare the adhesion-promoting  activi- 
ties of different matrix proteins, culture wells were coated for 1 h at room 
temperature with PBS containing 25 Ixg/ml fibronectin, laminin, collagens, 
or proteoglycans. Serum-spreading factor preparations were diluted 1:200 
(final protein concentration ~500 Ixg/ml). Fibronectin fragments were used 
at 25 txg/ml. In all other experiments, fibronectin was bound to the wells 
by taking advantage of  its affinity for denatured collagen. In this case culture 
wells were coated with 2 mg/ml gelatin, rinsed with PBS, and further in- 
cubated with the indicated concentrations of fibronectin. As shown in the 
Results section, gelatin coating alone did not support adhesion of hemopoi- 
eric cells. Adsorption of the matrix proteins to the dishes was checked by 
measuring adhesion of the proper cell types. Adsorption of cartilage pro- 
teoglycans was evaluated by antibodies to the proteoglycan core protein (2). 
About 0.5  Ixg/cm  2 of protein was absorbed to the plastic surface when 
coating was performed with 25 Ixg/ml. Cells were treated for 1 h before har- 
vesting with 20 ~tM cycloheximide  and plated in serumless medium contain- 
ing 20 I~M cycloheximide and  1 gM monensin to prevent synthesis and 
secretion of cellular  adhesive factors (9). After incubation for 1 h at 370C 
in a  humidified atmosphere containing 5% CO2,  unbound cells were re- 
moved by rinsing with PBS and adherent cells were fixed and stained with 
May-Griinwald Giernsa dye. To quantify adhesion, the light absorbance of 
the stained cells on the microtiter well surface was measured by an auto- 
mated photometer (Titertek, Elfab Oy,  Finland). We quantitated adhesion 
to Terasaki microtest wells (Falcon, Div. of  Becton Dickinson, Oxuard, CA) 
by directly counting the ceils on photomicrographs that cover the entire 
adhesion surface. To evaluate activity of the antibodies and peptides de- 
scribeaVabove, these were added to the adhesion medium at the beginning 
of the assay. 
Adhesion of fresh bone marrow cells was tested as described above. To 
quantify the adherent cells, these were detached by 0.01% trypsin plus I mM 
EDTA and counted. Cytospin smears were prepared from aliquots of both 
the adherent and nonadherent cell fractions, and morphological analysis 
was performed after fixation in methanol and staining with May-Griinwald 
Giemsa dye. 
Antibody Adsorption Experiments 
Affinity-purified  GP135 antibodies were adsorbed on many cell surface anti- 
gens that were immobilized on nitrocellulose paper (I0).  For this purpose, 
whole membrane proteins (250 I.tg of proteins) from Friend cells were pre- 
pared,  separated by  SDS  PAGE,  and  electrophoretically transferred to 
nitrocellulose filters as described below. GP145 isolated by immunoprecipi- 
tation and purified mouse plasma fibronectin were also bound to nitrocellu- 
lose by the same procedure. The filters were saturated with 5% BSA and 
cut in 2-mm slices. Each slice, with 5-10 I.tg of bound antigen, was in- 
cubated with 50 I~1 of medium containing 1 tag of affinity-purified GP135 
antibodies. After 2 h at room temperature, the supernatant was collected, 
concentrated, and tested in adhesion assay. 
Immi~noprecipitation and Immunoblotting of 
Membrane Proteins 
Membrane proteins were immunoprecipitated from metabolically labeled 
cells. Metabolic labeling was achieved by incubating Friend and WEHI-3B 
cells at a density of 5  ×  105/ml in complete medium containing 50 ~tCi/ml 
of [3H]6-D-glucosamine  (20 Ci/mM, Amersham Corp., Arlington Heights, 
IL) or in methionine-free medium containing 40  ~tCi/ml of [3SS]methio- 
nine (800 Ci/mM,  New England Nuclear,  Boston,  MA) for  15 h.  Sub- 
confluent monolayers of SR-BALB  fibroblasts were  incubated  with  25 
IxCi/ml of [35S]methionine.  Cell surface proteins were immunoprecipitated 
from intact cells (9, 10, 36) by incubating the cell suspension with anti-BHK 
serum or control preimmune serum (10 I.tl with 2  x  106 cells) for 1 h at 
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Cell line  Fn  Lam  SSF  Coil.I/Ill  Coil.IV  Gel  PG 
Friend (proEb)  +  ..... 
WEHI-3B  D+  (myelo/mono)  +  ..... 
K562  (undiff.  blasts)  +  ..... 
KG-1  (mybl/proM)  +  ..... 
HL-60  (proM)  +  ..... 
U937  (monoB/mono)  +  ..... 
BHK (fibroblasts)  +  +  +  +  +  - 
Hep-G2  (hepatoma)  -  +  -  +  +  + 
w 
Cells were plated on culture dishes coated with fibronectin (Fn), laminin (Lam), collagen types I and HI (Coil.l/Ill), collagen type IV (Coil.IV), serum-spreading 
factor (SSF),  chick sternal cartilage proteoglycan (PG), and gelatin (Gel), as described in details in the Materials and Methods section. Cell adhesion was evaluated 
after 1 h at 37°C. +, indicates adhesion of >70% of the plated cells.  -t- , indicates adhesion of 30-50% of the plated cells. -, indicates that <10% of the plated 
cells attached, proEb, proerythroblasts, myelo, myelocytes, mono, monocytes, undiff,  blasts, undifferentiated blasts, mybl, myeloblasts, proM, promyelocytes. 
monoB, monoblasts. 
4°C with gentle agitation. Unbound antibodies were then removed by wash- 
ing, and cells were extracted for 20 min at 0°C by Triton X-100 (50 mM 
Tris-HCl pH 7.4,  150 mM NaCI,  1 mM CaCI2, 0.5% Triton X-100 plus 2 
mM phenylmethylsulfonyl  fluoride, 6 p,M pepstatin, and 100 IttM leupeptin 
as protease inhibitors). After centrifiagation at 10,000 g for 30 min, soluble 
immunocomplexes were recovered by adsorption on protein A-Sepharose 
beads  (Pharmacia Fine Chemicals). After washing, bound material was 
eluted by boiling beads in 1% SDS and analyzed by SDS PAGE. This was 
carried out in 5-10%  acrylamide slab gels using the procedure described 
by Laemmli (18). When necessary, gels were processed for fluorography as 
described by Laskey et al.  (19), dried, and placed in contact with Kodak- 
X-Omat SO-282 film.  Molecular weight markers (under reducing condi- 
tions) were:  myosin (200,000),  phosphorylase B (93,000),  BSA (69,000), 
ovalbumin (46,000),  carbonic anhydrase (30,000), and lysozyme (14,000). 
Immunoblotting  analyses were performed on a crude membrane fraction. 
For this purpose, Friend cells were broken by Dounce homogenization in 
hypotonic buffer (20 mM Tris-HC1, pH 7.4). After removal of nuclei by low 
gravity sedimentation, membrane fragments were collected by centrifuga- 
tion at 100,000 g. The membrane pellet was solubilized by boiling in SDS, 
and proteins were separated by SDS PAGE and transferred to nitrocellulose 
paper by Western blotting, according to the procedure of Towbin et al. (39). 
lmmunostaining of blotted membrane proteins with the anti-BHK or the 
GP135 afffinity-purified  antibodies was performed as described previously 
(10). Due to the limited amount of affinity-purified GP135 antibodies avail- 
able, immunostaining with these antibodies was performed on a strip 2-ram 
wide covering the entire length of the lane that was cut out of the nitrocellu- 
lose  paper.  The  strip  was  incubated  with  100  I.tl of buffer containing 
50  lxg/ml antibodies in a  humidified chamber. After extensive washing, 
bound antibodies were revealed by t25I-labeled  protein A. 
Results 
Adhesion of  Hemopoietic Cells to Fibronectin 
The ability of a number of different hemopoietic cell lines 
to interact with various matrix components was evaluated by 
an adhesion assay (9, 36).  Lines tested included human and 
murine  leukemic cells  representative of different lineages 
and levels of differentiation (Table I). Cells were plated in 
serumless  medium  on  dishes  precoated  with  a  saturating 
concentration  (25  I~g/ml)  of fibronectin,  laminin,  serum 
spreading factor, types I, III, and IV collagen, gelatin, and 
cartilage proteoglycan. Most of these components are known 
to  be present  in  the  bone  marrow  stroma (1,  16,  43).  To 
block synthesis and  secretion of cellular adhesive factors, 
cells  were treated  with  cycloheximide and  monensin  (see 
Materials  and  Methods  section).  All  the hemopoietic cell 
lines tested adhered to fibronectin but failed to attach to the 
other  extracellular  matrix  proteins  (Table  I).  Adhesion 
parameters were studied with two murine cell lines represen- 
tative of both the erythroid (Friend) and the myeloid (WEHI- 
3B) lineage. The number of adherent cells reached a plateau 
level by 90  min at 37°C,  and the  extent of adhesion  was 
proportional to the amount of fibronectin used to coat the 
dishes. Both Friend (Fig.  1) and WEHI-3B cells responded 
to a threshold dose of 1.5 ~tg/ml fibronectin and showed max- 
imum adhesion on dishes coated with 25 txg/ml fibronectin. 
Attachment was always followed by a degree of spreading, 
which varied for the different cell lines.  Fig.  2  shows the 
results obtained with Friend and WEHI-3B cells. 
To verify whether adhesion to fibronectin was a peculiar 
property of leukemic cells adapted to in vitro culture, mouse 
bone marrow cells were tested.  A  significant proportion of 
the nucleated cells (45 +  7.4%) adhered to fibronectin (Table 
II). Morphological examination indicated that immature my- 
eloid and erythroid cells were preferentially recovered in the 
adherent fraction. On the other hand, most of fully differen- 
tiated cells did not attach to the coated dish.  A  negligible 
number of bone marrow cells adhered to dishes coated with 
laminin or gelatin.  It was thus concluded that adhesion to 
fibronectin is a general property of immature hemopoietic 
cells. 
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Figure 1. Adhesion of Friend cells to dishes coated with different 
amounts of fibmnectin.  Friend cells were plated on dishes coated 
with 2 mg/ml gelatin followed by the indicated concentrations  of 
fibronectin. After 1 h at 37°C, attached cells were fixed, stained, 
and counted  as specified in the Materials  and Methods  section. 
Adhesion values are expressed as percentage of the maximum adhe- 
sion and represent the mean of three different experiments. 
Giancotti  et al.  Interaction  of Hemopoietic  Cells  with  Fibronectin  431 Figure 2. Adhesion of Friend and WEHI-3B cells to fibronectin and laminin.  Friend (a and b) and WEHI-3B (c and d) cells were plated 
on dishes coated'with  25 lxg/ml fibronectin (a and c) or laminin (b and d). After  1 h at 37°C, attached cells were fixed and stained with 
May-GrOnwald Giemsa.  Bar, 25 lxm. 
Interaction of  Hemopoietic Cells with the 
Cell-attachment Site of  Fibronectin 
To assign the hemopoietic cell adhesion promoting activity 
to a specifc fibronectin domain, we have evaluated the adhe- 
sion of Friend and WEHI-3B cells on a number of purified 
fibronectin fragments. These were obtained by thermolysin 
digestion  of the  intact  molecule  (42)  and  consisted  of a 
ll0-kD fragment containing the cell-binding region, a 40-kD 
peptide  spanning  the  collagen binding  site,  and  two  frag- 
ments of 28 and 20 kD with affinity for heparin and fibrin, 
respectively.  As  shown in  Fig.  3,  Friend  cells adhered on 
dishes coated with the purified ll0-kD cell binding domain, 
but failed to adhere significantly to the other fibronectin frag- 
ments. The extent of adhesion and spreading on the  ll0-kD 
domain  was  comparable  to  that  observed  on  the  intact 
fibronectin molecule. Similar results were also obtained with 
WEHI-3B cells. These data indicate that the ll0-kD domain 
is involved in the adhesion of hemopoietic cells. Character- 
ization of the interaction of hemopoietic cells with fibronec- 
tin was extended using a  monoclonal antibody (MAB f33) 
that recognizes the cell binding site of fibronectin and pre- 
vents fibroblast adhesion (33). As shown in Fig. 4, a  and b, 
this  antibody  blocked  the  adhesion  of both  Friend  and 
WEHI-3B cells to fibronectin,  while the control antibody 
MAB 52,  which recognizes the gelatin binding domain of 
fibronectin (37), had no effect. Inhibition with the monoclo- 
nal antibody f33 was dose dependent and occurred up to a 
dilution of 10 ttg/ml. 
A  further analysis of the interaction of hemopoietic cells 
with fibronectin was performed using the synthetic cell at- 
tachment  promoting  peptide  Arg-Gly-Asp-Ser (28).  This 
peptide, added in solution to the adhesion medium together 
with hemopoietic cells at the beginning of the assay, could 
compete  with  substratum-bound  fibronectin  in  a  dose- 
dependent manner (Fig. 4, c and d).  Maximal inhibition of 
cell adhesion was achieved with 3 mM tetrapeptide. Equiva- 
lent concentrations of an inactive esapeptide Gly-Arg-Gly- 
Glu-Ser-Pro (29) or of an unrelated  peptide had no effect. 
These results suggest that the same site of fibronectin in- 
volved in fibroblast adhesion is also involved in the adhesion 
of Friend and WEHI-3B cells. 
Identification of  the Membrane Glycoprotein That 
Mediates Hemopoietic Cell Adhesion to Fibronectin 
To  identify  the  membrane  component  involved  in  hemo- 
poietic cell adhesion to fibronectin,  we used an antiserum 
(anti-BHK)  that  inhibits  adhesion  of hamster  and  murine 
fibroblasts to fibronectin (9, 35, 36). When the anti-BHK se- 
rum was added to Friend and WEHI-3B cells at the begin- 
ning of the adhesion assay, a dose-dependent inhibition was 
observed (not shown). 
Membrane proteins of [35S]methioninc-labeled  Friend and 
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Adherent 
Cell type  cells 
% 
Total bone marrow  45  +  5.4 
Blasts  36  5:18.3 
Promyelocytes  61  +  4.3 
Myelocytes  73  5:6.3 
Metamyelocytes  80  +  8.6 
Granulocytes  25 5:3.8 
Proerythroblasts  78 + 22.4 
Basophilic erythroblasts  70 5:2.6 
Polychromatophilic erythroblasts  58 5:3.7 
Acidophilic erythroblasts  25 5:6.4 
Erythrocytes  17 5:3.2 
4  x  10  + routine bone marrow cells were plated on a 50-ram dish coated with 
25 p.g/ml fibronectin. After 90 min at 37°C, unbound cells were collected by 
rinsing, while adherent cells were detached by trypsin plus EDTA. Cells from 
both fractions  were counted and examined for their  morphology  after  May- 
Griinwald Giemsa staining. The percentage of adhesion for each morphological 
class was calculated according to the formula A ×  B/C x  100, in which A is 
total no. of adherent cells, B is percentage of the given cell type in adherent 
fraction, and C is no. of cells of a given type plated. Data are the mean +  SD 
from three  different experiments  and include values for the granulocytic  and 
erythroid  lineages. 
WEHI-3B  cells  were  immunoprecipitated  with  the  anti- 
BHK serum and separated by SDS PAGE under nonreducing 
conditions. As shown in Fig.  5, anti-BHK antibodies spe- 
cifically recognized a major protein of 145,000 D on the sur- 
face of both Friend and WEHI-3B cells, together with minor 
components  (lanes  c  and  g).  The  145,000-D  component 
could also be labeled with [3H]glucosamine (Fig. 5, lane e) 
and is thus indicated as GP145. This glycoprotein was likely 
to contain intrachain disulfide bonds since it acquired a lower 
electrophoretic mobility when separated under reducing con- 
ditions (Fig. 5, lanes c' and e'). This peculiar electrophoretic 
behavior is common to the GP135 surface glycoprotein rec- 
ognized by the same antiserum on mouse fibroblasts and im- 
plicated in the adhesion of these cells to fibronectin (9,  I(3). 
These data suggested a structural and functional relation- 
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Figure 3.  Adhesion of Friend cells to proteolytically derived fi- 
bronectin fragments. Friend cells were plated on dishes coated with 
25 Ixg/ml of fibronectin (FN) or the Cell (llOK), Gel (4OK), Hep- 
1/Fib-1 (28K), and Fib-2 (2OK) domains of fibronectin (see refer- 
ence 23 and Materials and Methods section). After 1 h at 37°C, 
attached cells were fixed, stained, and counted as specified in the 
Materials and Methods section. Adhesion values are expressed as 
percentage of the maximum adhesion and represent the mean of 
three different experiments. 
ship between hemopoietic cells GP145 and fibroblast GPI35. 
To further investigate this point, we used monospecific anti- 
bodies purified by affinity on nitrocellulose-bound GP135 
(10). The purification of these antibodies from the anti-BHK 
serum is described in the Materials and Methods section. 
Immunoblotting experiments on a crude membrane fraction 
of Friend  ceils  indicated  that purified antibodies  reacted 
selectively with GP145  (Fig. 6, lane c). The two molecules 
are thus antigenically related. 
To  investigate  the  role  of  GP145  in  the  adhesion  of 
hemopoietic cells to fibronectin, we took advantage of the 
affinity-purified GP135  antibodies.  When  added  together 
with the cells at the beginning of the adhesion assay,  these 
antibodies inhibited fibronectin-mediated adhesion of both 
Friend and WEHI-3B cells, while preimmune IgG had no ef- 
fect (Fig. 7). Inhibition was dose dependent and reached a 
value of 80%  at 40 ~tg/ml.  Since GP135  antibodies recog- 
nized only GP145 among membrane proteins of hemopo:.etic 
cells, the simplest interpretation of this result is that GP135 
antibodies block cell adhesion by directly interacting with 
GP145.  This  interpretation  was  confirmed by  adsorption 
experiments.  Nitrocellulose-bound membrane  antigens  of 
Friend ceils,  including  GP145,  other unrelated membrane 
polypeptides, and fibronectin, were used to adsorb afffinity- 
purified GP135 antibodies (see Materials and Methods sec- 
tion for details). Adsorption with GP145 removed virtually 
all (87 % +  4) the adhesion-preventing activity. On the con- 
trary,  adsorption with equivalent amounts of either fibro- 
nectin or membrane polypeptides unrelated to GP145  was 
uneffective and removed <10% (+ 3) of the activity. By the 
above-described results,  we  conclude that  the  membrane 
glycoprotein GP145 mediates adhesion of hemopoietic cells 
to fibronectin. 
Discussion 
In this paper we report that myeloid and erythroid hemo- 
poietic cells interact with and adhere to fibronectin. None of 
the cell lines tested adhered to laminin, types I, M, and IV 
collagen, or proteoglycans which, together with fibronectin, 
represent the major matrix components of the bone marrow 
stroma (1, 16, 43). It is generally accepted that contiguity of 
hemopoietic cells with the bone marrow stroma is necessary 
for the maintenance of hemopoiesis (5, 12, 38). The in vitro 
interaction of hemopoietic cells with fibronectin, reported in 
this  paper,  might  reproduce  a  molecular  mechanism  by 
which hemopoietic cells are anchored to the bone marrow 
stroma, near the proper signals for their proliferation and 
differentiation (6). Blood cells are normally released to the 
circulation only when fully differentiated. In this respect, 
note that few end-stage cells (erythrocytes and granulocytes) 
adhered  to  fibronectin.  It  has  also  been  reported  that 
dimethylsulfoxide-induced  differentiation of  murine erythro- 
leukemia ceils is accompanied by loss of their ability to at- 
tach  to  fibronectin (26).  Thus,  in  the  erythroid (27)  and 
granulocytic lineages, loss of fibronectin-binding ability dur- 
ing differentiation may be the underlying cause for release 
of end-stage ceils into the circulation. 
We have found that the same site of fibronectin that func- 
tions in fibroblast and platelet adhesion is also involved in 
the adhesion of  hemopoietic cells. In fact, a monoclonal anti- 
body to the fibroblast binding site of fibronectin (33) also 
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Figure 4. Identification of the fibronectin site involved in the adhesion of hemopoietic cells. (a and b) Friend (a) and WEHI-3B (b) cells 
were plated on dishes coated with 2 mg/ml gelatin followed by 25 Ixg/ml fibronectin in the presence of fibronectin monoclonal antibodies 
of known specificity.  The monoclonal antibody f33 is directed against the cell binding site and was previously shown to inhibit fibroblast 
adhesion to fibronectin. The monoclonal antibody MAB 52 is directed against the gelatin-binding domain. Both antibodies were used at 
20 I~g/ml. (c and d) Friend (c) and WEHI-3B (d) cells were plated on dishes coated as specified above.  The peptide Arg-Gly-Asp-Ser 
(RGDS), corresponding to the sequence of the cell attachment site, or a control peptide (substance P) was added at different concentrations 
at the beginning of the assay. After 1 h at 37°C, attached cells were fixed, stained, and counted as specified in the Materials and Methods 
section. Adhesion values are expressed as percentage of the maximum adhesion and represent the mean of three different experiments. 
prevented the adhesion of hemopoietic cells.  Moreover, the 
tetrapeptide  Arg-Gly-Asp-Ser,  which provides the recogni- 
tion signal for fibroblasts  (28)  and platelets  (11), competed 
with substratum-bound  fibronectin for the hemopoietic cell 
surface. 
A  membrane glycoprotein of 145  kD (GP145)  appears to 
be an important effector of the interaction of murine hemo- 
poietic cells with fibronectin, since affinity-purified antibod- 
ies that reacted with this molecule blocked their adhesion. 
Hemopoietic cell  lines have the distinctive property to ad- 
here  selectively  to  fibronectin.  By contrast,  other  mesen- 
chymal cell lines adhere to more than one extracellular ma- 
trix  molecule,  including  fibronectin,  laminin,  vitronectin 
(serum-spreading factor), and collagens, presumably through 
different cell surface receptors (15, 20, 22, 23, 31).  This sug- 
gests that GP145 may be regarded  as a  fibronectin-specific 
mediator of cell adhesion. 
The data  presented  in  this  paper indicate  that GP145  of 
hemopoietic cells is related to a cell surface adhesive glyco- 
protein,  GP135,  of mouse  fibroblasts  (9,  10).  GP135  was 
identified as a critical component because its selective cleav- 
age from the cell  surface led to loss of fibroblast adhesion 
to fibronectin (9). The fibroblast GP135 (9, 10) and the hemo- 
poietic  cells  GP145  displayed  a  decreased  electrophoretic 
mobility in the presence of reducing agents,  suggesting the 
presence of intrachain disulfide bonds in both molecules. In 
addition,  GP135  monospecific  antibodies  did  react  with 
GP145  and  blocked  the  adhesion  to  fibronectin  of  both 
fibroblasts (10) and hemopoietic cells, indicating that the two 
glycoproteins are both antigenically and functionally related. 
The two proteins,  however,  are  not  identical,  as they dis- 
played different molecular weights. This can be attributed to 
a  different extent of glycosylation of the  same polypeptide 
backbone. Alternatively, the two molecules may have related 
but distinct primary sequences, being coded by two different 
genes. 
The Journal of Cell Biology, Volume 103, 1986  434 Figure 5. Membrane proteins recognized by the anti-BHK serum on the surface of Friend and WEHI-3B ceils. Lane a, membrane proteins 
of [35S]methionine-labeled SR-Balb fibroblasts were immunoprecipitated with the anti-BHK serum and separated under nonreducing con- 
ditions for comparison. Lanes b-e, membrane proteins of Friend cells, labeled with [35S]methionine (b and c) or [3H]glucosamine (d and 
e), were immunoprecipitated with anti-BHK (c and e) or preimmune serum (b and d) and separated by SDS PAGE under nonreducing 
conditions. Lanes e'-b', the same samples separated under reducing conditions. Lanes f-g, membrane proteins of [asS]methionine-labeled 
WEHI-3B cells were immunoprecipitated with anti-BHK (g) or preinunune serum (f) and separated under nonreducing conditions. The 
positions of both hemopoietic cell GPI45  and  fibroblast GP135 are indicated for reference.  Migration of molecular weight markers 
(×  10  -3) is shown on the right. 
Figure  6.  Antigenic relationship between GP145  of hemopoietic 
cells and the fibroblast GPB5.  Proteins from a crude membrane 
fraction of Friend cells were separated by SDS PAGE under non- 
reducing conditions and, after transfer to nitrocellulose  paper, were 
reacted with 50 Isg/ml of afffinity-purified antibodies to fibroblast 
GP135 (c) or anti-BHK immunoglobulins (d).  To use a minimal 
amount  of antibodies, a  2-ram wide strip was excised from the 
nitrocellulose  filter for incubation with affinity-purified  GP135 anti- 
bodies. Bound antibodies were revealed by ~25I-labeled  protein A. 
To localize the position of GP145, membrane proteins immunopre- 
cipitated with anti-BHK (b) or preimmune serum (a) from the sur- 
face of [3SS]methionine-labeled  cells were separated in the same 
gel and  transferred to nitrocellulose for reference.  Migration of 
molecular weight markers (x  10  -3) is shown on the right. 
The GP145  molecule may resemble other  140-kD glyco- 
proteins  involved in  adhesion  to  fibronectin,  which  show 
altered  SDS  PAGE  mobilities in  the  absence  of reducing 
agents.  These were identified by different experimental ap- 
proaches on human  MG-63  osteosarcoma cells (30),  Chi- 
nese hamster ovary ceils (3), as well as chick myoblasts and 
fibroblasts (13, 25). More recently, the membrane glycopro- 
tein GPIIIa was identified as the fibronectin-binding site on 
human platelet surface (8). This molecule occurs in a com- 
plex with the glycoprotein GPIIb at the surface of activated 
platelets  and  its  electrophoretic  mobility  is  affected  by 
disulfide bond reduction (21)  with a  pattern similar to that 
reported here for the GP145 of hemopoietic cells and else- 
where for the fibroblast GP135  (9,  10). 
Even if it is not yet known whether all these membrane 
glycoproteins are structurally related, clearly a  set of mem- 
brane glycoproteins with similar properties mediate the in- 
teraction of fibroblasts, platelets, and hemopoietic cells with 
fibronectin. 
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Note Added in Proof:  While this paper was under editorial processing, V. 
Patel and H. E Lodish (J. Cell Biol.,  1986, 102:449-456) have reported that 
undifferentiated  marine erythroleukemia  cells express a fibronectin  receptor 
Giancotti  et al. Interaction of Hemopoietic Cells with Fibronectin  435 Figure 7.  Inhibition of Friend and WEHI-3B cell adhesion by afffinity-purified antibodies to GPI35.  Friend (a and b) and WEHI-3B cells 
(c and d) were plated on dishes coated with 2  mg/ml gelatin followed by 25 ~tg/ml fibronectin,  At the beginning of the assay, 40 Ixg/ml 
affinity-purified GP135 (b and d) or control immunoglobulins (a and c) were added to the wells.  After 1 h  at 37°C,  attached cells were 
fixed and  stained with  May-Griinwald  Giemsa.  Bar,  25  ~tm. 
with properties in common with those reported here for the GP145 of my- 
eloid and erythroid cells. 
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